Possibilities оf use of testosterone undecanoate in treatment in stroke male patients with type 2 diabetes mellitus

2014

Андрология и генитальная хирургия, Vol 13, Iss 4, Pp 13-17 (2014)

We have studied 154 men with the first hemispheric ischemic stroke. Clinical and laboratory studies have revealed the androgen deficiency in 66.3 %, with its frequency higher in patients with diabetes mellitus type 2 (50 % and 26.3 %, respectively). Forty-two men with diabetes mellitus type 2 and acquired androgenic deficit received replacing treatment with testosterone undecanoate. After 2 years from the beginning of treatment, there were the decrease in clinical severity of androgenic deficit, the increase of total and free testosterone levels, and muscle power in the main group compared to the controls. Body mass index, glycated hemoglobin, cholesterol, triglycerides, low density lipoproteins have decreased as well. Secondary stroke has developed in 3 (7.1 %) patients of the main group and in 5 (16.6 %) controls. The treatment with androgens has a positive effect on risk factors of secondary ischemic stroke. It is an effective method for improvement of social adaptation of men survived after the stroke..

article

Russian

ABV-press, 2014.

ишемический инсульт, андрогенный дефицит, сахарный диабет, тестостерон, Surgery, RD1-811, Diseases of the genitourinary system. Urology, RC870-923